Mao Mu

1.1k total citations
34 papers, 844 citations indexed

About

Mao Mu is a scholar working on Hepatology, Molecular Biology and Epidemiology. According to data from OpenAlex, Mao Mu has authored 34 papers receiving a total of 844 indexed citations (citations by other indexed papers that have themselves been cited), including 14 papers in Hepatology, 11 papers in Molecular Biology and 11 papers in Epidemiology. Recurrent topics in Mao Mu's work include Liver physiology and pathology (10 papers), Liver Disease Diagnosis and Treatment (9 papers) and Hepatitis B Virus Studies (4 papers). Mao Mu is often cited by papers focused on Liver physiology and pathology (10 papers), Liver Disease Diagnosis and Treatment (9 papers) and Hepatitis B Virus Studies (4 papers). Mao Mu collaborates with scholars based in China, United States and Germany. Mao Mu's co-authors include Xueke Zhao, Juanjuan Zhu, Yiju Cheng, Jing Yang, Baofang Zhang, Shi Zuo, Shuang Lü, Yumei Yao, Lei Yu and Yaxin Hu and has published in prestigious journals such as SHILAP Revista de lepidopterología, PLoS ONE and Scientific Reports.

In The Last Decade

Mao Mu

33 papers receiving 835 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Mao Mu China 14 337 254 217 97 73 34 844
Xueke Zhao China 20 522 1.5× 321 1.3× 255 1.2× 164 1.7× 99 1.4× 58 1.2k
Xuehua Sun China 17 338 1.0× 245 1.0× 186 0.9× 123 1.3× 34 0.5× 49 877
Wensong Ge China 12 374 1.1× 222 0.9× 91 0.4× 123 1.3× 45 0.6× 30 822
Yanchun Li China 17 420 1.2× 197 0.8× 76 0.4× 118 1.2× 56 0.8× 56 952
Jinghua Jiang China 18 334 1.0× 177 0.7× 114 0.5× 158 1.6× 32 0.4× 41 858
Marta Benet Spain 13 633 1.9× 273 1.1× 87 0.4× 125 1.3× 60 0.8× 26 1.1k
Xiufen Li China 16 426 1.3× 125 0.5× 83 0.4× 92 0.9× 103 1.4× 58 1.1k
Jae Kwang Kim South Korea 18 345 1.0× 166 0.7× 66 0.3× 100 1.0× 50 0.7× 44 851
Yang Tan China 22 472 1.4× 199 0.8× 107 0.5× 228 2.4× 56 0.8× 59 1.3k
Wonbeak Yoo South Korea 15 275 0.8× 199 0.8× 79 0.4× 88 0.9× 84 1.2× 29 752

Countries citing papers authored by Mao Mu

Since Specialization
Citations

This map shows the geographic impact of Mao Mu's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Mao Mu with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Mao Mu more than expected).

Fields of papers citing papers by Mao Mu

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Mao Mu. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Mao Mu. The network helps show where Mao Mu may publish in the future.

Co-authorship network of co-authors of Mao Mu

This figure shows the co-authorship network connecting the top 25 collaborators of Mao Mu. A scholar is included among the top collaborators of Mao Mu based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Mao Mu. Mao Mu is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Wang, Yuqing, et al.. (2025). Association between exposure to volatile organic compounds and atherogenic index of plasma in NHANES 2011–2018. Scientific Reports. 15(1). 9024–9024. 1 indexed citations
2.
Zhao, Xiaofei, et al.. (2025). Scalable & secure real-world asset tokenization using ethereum staking & layer-2 solutions. Peer-to-Peer Networking and Applications. 18(5).
4.
Zhu, Juanjuan, et al.. (2024). Tectorigenin improves metabolic dysfunction-associated steatohepatitis by down-regulating tRF-3040b and promoting mitophagy to inhibit pyroptosis pathway. Biochemical and Biophysical Research Communications. 720. 150118–150118. 2 indexed citations
5.
Wu, Yiqi, et al.. (2024). Nintedanib attenuates NLRP3 inflammasome-driven liver fibrosis by targeting Src signaling. International Immunopharmacology. 143(Pt 3). 113630–113630. 2 indexed citations
6.
Zhao, Xueke, et al.. (2023). Anlotinib Attenuates Liver Fibrosis by Regulating the Transforming Growth Factor β1/Smad3 Signaling Pathway. Digestive Diseases and Sciences. 68(11). 4186–4195. 4 indexed citations
7.
Cong, Shuo, Yongmei Liu, Yi Li, et al.. (2021). MiR-571 affects the development and progression of liver fibrosis by regulating the Notch3 pathway. Scientific Reports. 11(1). 21854–21854. 11 indexed citations
9.
Liu, Yongmei, Shuo Cong, Zhuo Cheng, et al.. (2020). Platycodin D alleviates liver fibrosis and activation of hepatic stellate cells by regulating JNK/c-JUN signal pathway. European Journal of Pharmacology. 876. 172946–172946. 53 indexed citations
10.
Zuo, Shi, Shuang Lü, Yinying Lu, et al.. (2019). Bone morphogenetic protein-7 represses hepatic stellate cell activation and liver fibrosis via regulation of TGF-β/Smad signaling pathway. World Journal of Gastroenterology. 25(30). 4222–4234. 46 indexed citations
11.
Mu, Mao, et al.. (2018). Ferulic acid attenuates liver fibrosis and hepatic stellate cell activation via inhibition of TGF-β/Smad signaling pathway. SHILAP Revista de lepidopterología. 2 indexed citations
12.
Mu, Mao, et al.. (2018). Knockdown of HOXA transcript at the distal tip suppresses the growth and invasion and induces apoptosis of oral tongue squamous carcinoma cells. SHILAP Revista de lepidopterología. 2 indexed citations
13.
Zhu, Lili, Tingting Ren, Zixin Zhu, et al.. (2018). Thymosin-β4 Mediates Hepatic Stellate Cell Activation by Interfering with CircRNA-0067835/miR-155/FoxO3 Signaling Pathway. Cellular Physiology and Biochemistry. 51(3). 1389–1398. 45 indexed citations
14.
Hu, Yaxin, Xinyan Liu, Zhuo Cheng, et al.. (2018). The role of AKT and FOXO3 in preventing ovarian toxicity induced by cyclophosphamide. PLoS ONE. 13(8). e0201136–e0201136. 32 indexed citations
15.
Zhao, Xueke, Yiju Cheng, Ming Cheng, et al.. (2016). Focal Adhesion Kinase Regulates Fibroblast Migration via Integrin beta-1 and Plays a Central Role in Fibrosis. Scientific Reports. 6(1). 19276–19276. 122 indexed citations
16.
Yu, Lei, Yiju Cheng, Yumei Yao, et al.. (2015). Quantitative assessment of common genetic variations in HLA-DP with hepatitis B virus infection, clearance and hepatocellular carcinoma development. Scientific Reports. 5(1). 14933–14933. 26 indexed citations
17.
Quan, Peng, Mao Mu, Xinfu Zhang, et al.. (2014). Enantioselective skin permeation of ibuprofen enantiomers: mechanistic insights from ATR-FTIR and CLSM studies based on synthetic enantiomers as naphthalimide fluorescent probes. Expert Opinion on Drug Delivery. 11(10). 1513–1523. 13 indexed citations
18.
Zhao, Xueke, et al.. (2014). Effect of Maotai liquor on P53 gene in primary hepatocellular carcinoma induced by compound factors in rats. Chinese Medical Journal. 127(2). 378–380. 1 indexed citations
19.
Liang, Ping, Bin Qin, Mao Mu, et al.. (2013). Prelog and anti-Prelog stereoselectivity of two ketoreductases from Candida glabrata. Biotechnology Letters. 35(9). 1469–1473. 30 indexed citations
20.
Mu, Mao, et al.. (1997). Ontogenesis of rat cochlea. A quantitative study of the organ of Corti. Developmental Brain Research. 99(1). 29–37. 31 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026